VALOS
Private Company
Funding information not available
Overview
VALOS is a Milan-based, privately-held service provider in the clinical research sector, offering specialized statistical and data management support for drug development. With over 500 clinical trials supported and a team of 80+ programmers, the company leverages deep regulatory expertise (CDISC, GCP, GDPR) and industry-standard software platforms to deliver submission-ready outputs. Its business model is purely service-based, generating revenue by outsourcing critical functions of clinical trials, with leadership anchored by a founder with over two decades of statistical programming experience.
Technology Platform
Integrated clinical trial service workflow utilizing industry-standard software (Clinical SAS®, Medidata RAVE, Oracle Inform) and deep expertise in regulatory data standards (CDISC, GCP, 21 CFR Part 11). Offers applied data science and Real-World Evidence (RWE) analytics services.
Opportunities
Risk Factors
Competitive Landscape
VALOS competes in a fragmented market dominated by large, full-service CROs (e.g., IQVIA, Parexel) and many small-to-mid-sized specialized service providers. Its differentiation is its focused expertise in statistical programming and data management, competing on quality, regulatory knowledge, and customer service rather than scale. Key competitors include other niche statistical CROs and the biometrics divisions of larger organizations.